Pyrophosphoric Acid

Pyrophosphoric Acid

SCHEMBL621775

O=P(O)(O)OP(=O)(O)O.O=P(O)(O)OP(=O)(O)O.O=P(O)(O)OP(=O)(O)O.[CaH2].[CaH2].[CaH2]

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.91
BLM P54132 1/20 0.91
TDP1 Q9NUW8 1/20 0.91
CA4 P22748 1/20 0.37
CA2 P00918 1/20 0.36
INPPL1 O15357 2/20 0.35
INPP5A Q14642 2/20 0.35
SMPD1 P17405 1/20 0.35
INPP5B P32019 1/20 0.35
BTN3A1 O00481 2/20 0.35
ITPR3 Q14573 3/20 0.33
SLC34A1 Q06495 1/20 0.33
ITPR2 Q14571 1/20 0.33
ITPR1 Q14643 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrophosphoric Acid SCHEMBL27784233 1.00 FDPS (0.91) FDPSBLMTDP1CA4CA2
Pyrophosphoric Acid SCHEMBL621307 1.00 FDPS (0.91) FDPSBLMTDP1CA4CA2
Pyrophosphoric Acid SCHEMBL28370379 1.00 FDPS (0.91) FDPSBLMTDP1CA4CA2
Pyrophosphoric Acid SCHEMBL2460231 1.00 FDPS (0.91) FDPSBLMTDP1CA4CA2
Pyrophosphoric Acid SCHEMBL5550825 1.00 FDPS (0.91) FDPSBLMTDP1CA4CA2
Pyrophosphoric Acid SCHEMBL18670528 1.00 FDPS (0.91) FDPSBLMTDP1CA4CA2
Pyrophosphoric Acid SCHEMBL4418859 1.00 FDPS (0.91) FDPSBLMTDP1CA4CA2
Pyrophosphoric Acid SCHEMBL440052 1.00 FDPS (0.91) FDPSBLMTDP1CA4CA2
Pyrophosphoric Acid SCHEMBL21433694 1.00 FDPS (0.91) FDPSBLMTDP1CA4CA2
Pyrophosphoric Acid SCHEMBL7650519 1.00 FDPS (0.91) FDPSBLMTDP1CA4CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 246 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210198152-A1 CERAMIC PARTICLE AND METHOD FOR PRODUCING THE SAME METAL INDUSTRIES RESEARCH & DEVELOPMENT CENTRE (TW) 2021-07-01 US claimed
EP-2684849-B1 Method and device for treating drinking water BWT AG (AT) 2019-10-30 EP claimed
EP-2269663-B1 BONE GRAFT AND BIOCOMPOSITE ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2018-03-07 EP claimed
US-20170368182-A1 Pharmaceutical Semi-Solid Gels with Entrapped Calcium Phosphate Nanoparticles BELMONT UNIVERSITY 2017-12-28 US claimed
EP-3229783-A1 PHARMACEUTICAL SEMI-SOLID GELS WITH ENTRAPPED CALCIUM PHOSPHATE NANOPARTICLES Belmont University (US) 2017-10-18 EP claimed
US-20170175260-A1 CERAMIC/POLYMER COMPOSITE MATERIAL AND METHOD FOR FABRICATING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2017-06-22 US claimed
WO-2016094571-A1 PHARMACEUTICAL SEMI-SOLID GELS WITH ENTRAPPED CALCIUM PHOSPHATE NANOPARTICLES BELMONT UNIVERSITY (US) 2016-06-16 WO claimed
EP-2448609-B1 BONE GRAFT AND BIOCOMPOSITE FOR PROSTHETIC DENTISTRY ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2014-10-08 EP claimed
US-8834935-B2 Bone graft and biocomposite for prosthetic dentistry ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2014-09-16 US claimed
WO-2014099852-A1 IMPROVED STRUCTURING USING AN EXTERNAL STRUCTURANT AND A COSMOTROPE THE PROCTER & GAMBLE COMPANY (US) 2014-06-26 WO claimed
US-20140179591-A1 STRUCTURING USING AN EXTERNAL STRUCTURANT AND A COSMOTROPE THE PROCTER & GAMBLE COMPANY (US) 2014-06-26 US claimed
EP-2746377-A1 Improved structuring using an external structurant and a cosmotrope The Procter & Gamble Company (US) 2014-06-25 EP claimed
EP-2448609-A2 BONE GRAFT AND BIOCOMPOSITE FOR PROSTHETIC DENTISTRY Armbruster Biotechnology GmbH (DE) 2012-05-09 EP claimed
US-20120107407-A1 BONE GRAFT AND BIOCOMPOSITE FOR PROSTHETIC DENTISTRY ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2012-05-03 US claimed
WO-2011000970-A2 BONE GRAFT AND BIOCOMPOSITE FOR PROSTHETIC DENTISTRY ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2011-01-06 WO claimed
EP-2269663-A2 Bone graft and biocomposite for prosthetic dentistry Armbruster Biotechnology GmbH (DE) 2011-01-05 EP claimed
US-6689467-B1 Composition comprising an inorganic coating and a core comprising at least a polyhydroxyl compound RHODIA CHIMIE (FR) 2004-02-10 US claimed
US-5783635-A ARTIFICIAL MARBLE, PARTICLES OF CROSSLINKED DIVINYLBENZENE-STYRENE RESIN, GLASS OR ALUMINUM HYDROXIDE POWDER FILLER, BATHROOM AND KITCHEN FIXTURES AND COUNTERS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-07-21 US claimed
EP-0806454-A2 An unsaturated polyester resin composition Takeda Chemical Industries, Ltd. (JP) 1997-11-12 EP claimed
JP-63238022-A None JP disclosed
JP-1101976-A None JP disclosed
JP-1101977-A None JP disclosed
JP-61247610-A None JP disclosed
US-12636299-B2 Terpenoid derivatives, pharmaceutical preparations containing these derivatives and their use in neuroprotection UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2026-05-26 US disclosed
US-12376612-B2 Edible concentrate comprising microfibrillated cellulose CONOPCO INC. (US) 2025-08-05 US disclosed
US-12319694-B2 Heterocyclic nitrogen-containing purine derivatives, pharmaceutical preparations containing these derivatives and their use in neuroprotection UNIVERZITA PALACKEHO (CZ) 2025-06-03 US disclosed
EP-3946271-B1 METHOD OF PRODUCTION OF A COMPOSITE OF YEAST-DERIVED BETA GLUCAN PARTICLE WITH INCORPORATED POORLY-WATER-SOLUBLE LOW-MOLECULAR-WEIGHT COMPOUND, PHARMACEUTICAL PREPARATION AND USE THEREOF VS CHEMICKO TECHNOLOGICKA V PRAZE (CZ) 2024-12-25 EP disclosed
EP-3924353-B1 HETEROCYCLIC NITROGEN-CONTAINING PURINE DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN NEUROPROTECTION UNIV PALACKEHO (CZ) 2024-04-24 EP disclosed
WO-2024080123-A1 COMPOSITION 住友化学株式会社 2024-04-18 WO disclosed
WO-2024063737-A1 PRODUCTION AND USE OF BACTERIAL CELLULOSE IN PURE FORM OR BY IMPREGNATION OF VARIOUS AGENTS AND PRODUCED IN SPHERICAL FORM FOR BONE REGENERATION, ALONE AND IN COMBINATION WITH VARIOUS GRAFT MATERIALS ATATÜRK ÜNİVERSİTESİ REKTÖRLÜĞÜ BİLİMSEL ARAŞTIRMA PROJELERİ ( BAP ) KOORDİNASYON BİRİMİ (TR) 2024-03-28 WO disclosed
US-20230414645-A1 TERPENOID DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN NEUROPROTECTION UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2023-12-28 US disclosed
US-20230365616-A1 CHOLESTANE DERIVATIVES, PREPARATIONS CONTAINING THESE DERIVATIVES AND USE THEREOF UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2023-11-16 US disclosed
CN-116891957-A Covering agent for smelting carbonless heating copper-iron alloy and preparation method thereof 江西省科学院应用物理研究所 2023-10-17 CN disclosed
EP-4255916-A2 TERPENOID DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN NEUROPROTECTION Univerzita Palackého v Olomouci (CZ) 2023-10-11 EP disclosed
EP-4232457-A1 CHOLESTANE DERIVATIVES, PREPARATIONS CONTAINING THESE DERIVATIVES AND USE THEREOF Univerzita Palackého v Olomouci (CZ) 2023-08-30 EP disclosed
EP-4107145-B1 PYRAZOLE-INDOLE CONJUGATES FOR PHOTODYNAMIC TREATMENT OF CANCER AND BACTERIAL INFECTIONS UNIV PALACKEHO (CZ) 2023-08-02 EP disclosed
WO-2023131362-A1 PHENYLPROPANOID DERIVATIVES USTAV EXPERIMENTALNI BOTANIKY AV ČR, V. V. I. (CZ) 2023-07-13 WO disclosed
US-11643413-B2 9-(2-oxacycloalkyl)-9H-purine-2,6-diamine derivatives and their use for the treatment of skin disorders UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2023-05-09 US disclosed
EP-4107145-A1 PYRAZOLE-INDOLE CONJUGATES FOR PHOTODYNAMIC TREATMENT OF CANCER AND BACTERIAL INFECTIONS Univerzita Palackého v Olomouci (CZ) 2022-12-28 EP disclosed
CN-110234237-B Edible concentrate comprising microfibrillated cellulose 联合利华知识产权控股有限公司 2022-11-08 CN disclosed
EP-4069370-A1 PHENOLIC DIHYDROBENZOFURANE DERIVATIVES, MEDICAL AND COSMETIC PREPARATIONS CONTAINING THESE DERIVATIVES, AND USE THEREOF Univerzita Palackého v Olomouci (CZ) 2022-10-12 EP disclosed
US-20220192985-A1 METHOD OF PRODUCTION OF A COMPOSITE OF YEAST-DERIVED BETA GLUCAN PARTICLE WITH INCORPORATED POORLY-WATER-SOLUBLE LOW-MOLECULAR-WEIGHT COMPOUND, PHARMACEUTICAL PREPARATION AND USE THEREOF VYSOKA SKOLA CHEMICKO-TECHNOLOGICKA V PRAZE (CZ) 2022-06-23 US disclosed
EP-3615535-B1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS UNIV PALACKEHO (CZ) 2022-06-15 EP disclosed
WO-2022117133-A2 TERPENOID DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN NEUROPROTECTION Univerzita Palackého v Olomouci (CZ) 2022-06-09 WO disclosed
WO-2022083809-A1 CHOLESTANE DERIVATIVES, PREPARATIONS CONTAINING THESE DERIVATIVES AND USE THEREOF Univerzita Palackého v Olomouci (CZ) 2022-04-28 WO disclosed
US-20220127269-A1 HETEROCYCLIC NITROGEN-CONTAINING PURINE DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN NEUROPROTECTION UNIVERZITA PALACKEHO (CZ) 2022-04-28 US disclosed
US-11253556-B2 Lactobacillus fermentum GKF3, composition comprising the strain and method for improving psychataxia using the same GRAPE KING BIO LTD (TW) 2022-02-22 US disclosed
EP-3946271-A1 METHOD OF PRODUCTION OF A COMPOSITE OF YEAST-DERIVED BETA GLUCAN PARTICLE WITH INCORPORATED POORLY-WATER-SOLUBLE LOW-MOLECULAR-WEIGHT COMPOUND, PHARMACEUTICAL PREPARATION AND USE THEREOF Vysoká skola chemicko-technologická v Praze (CZ) 2022-02-09 EP disclosed
EP-3924353-A1 HETEROCYCLIC NITROGEN-CONTAINING PURINE DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN NEUROPROTECTION Univerzita Palackého (CZ) 2021-12-22 EP disclosed
EP-3601287-B1 2,6-DISUBSTITUTED-9-CYCLOPENTYL-9H-PURINES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS UNIV PALACKEHO (CZ) 2021-12-15 EP disclosed
US-11186583-B2 5-alkylthio-7-[(4-arylbenzyl)amino]-1(2)H-pyrazolo[4,3-d]pyrimidines for treatment of lymphoma UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2021-11-30 US disclosed
EP-3749670-B1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA UNIV PALACKEHO (CZ) 2021-10-06 EP disclosed
US-11058733-B2 Active substances of Bifidobacterium lactis GKK2, composition comprising the same and method of promoting longevity using the same GRAPE KING BIO LTD (TW) 2021-07-13 US disclosed
US-20210198152-A1 CERAMIC PARTICLE AND METHOD FOR PRODUCING THE SAME METAL INDUSTRIES RESEARCH & DEVELOPMENT CENTRE (TW) 2021-07-01 US disclosed
WO-2021110185-A1 PHENOLIC DIHYDROBENZOFURANE DERIVATIVES, MEDICAL AND COSMETIC PREPARATIONS CONTAINING THESE DERIVATIVES, AND USE THEREOF UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2021-06-10 WO disclosed
US-11028087-B2 2,6-disubstituted-9-cyclopentyl-9H-purines, use thereof as medicaments, and pharmaceutical compositions UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2021-06-08 US disclosed
EP-3749670-A1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA Univerzita Palackeho v Olomouci (CZ) 2020-12-16 EP disclosed
US-20200361943-A1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2020-11-19 US disclosed
WO-2020200337-A1 METHOD OF PRODUCTION OF A COMPOSITE OF YEAST-DERIVED BETA GLUCAN PARTICLE WITH INCORPORATED POORLY-WATER-SOLUBLE LOW-MOLECULAR-WEIGHT COMPOUND, PHARMACEUTICAL PREPARATION AND USE THEREOF VYSOKA SKOLA CHEMICKO-TECHNOLOGICKA V PRAZE (CZ) 2020-10-08 WO disclosed
WO-2020164648-A1 HETEROCYCLIC NITROGEN-CONTAINING PURINE DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN NEUROPROTECTION UNIVERZITA PALACKEHO (CZ) 2020-08-20 WO disclosed
US-20200155623-A1 Lactobacillus Fermentum GKF3, Composition Comprising the Strain and Method for Improving Psychataxia Using the Same GRAPE KING BIO LTD (TW) 2020-05-21 US disclosed
US-20200157105-A1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2020-05-21 US disclosed
EP-3579706-B1 EDIBLE CONCENTRATE COMPRISING MICROFIBRILLATED CELLULOSE UNILEVER NV (NL) 2020-05-13 EP disclosed
EP-3325480-B1 5-SUBSTITUTED-7-[4-(SUBSTITUTED) BENZYL]AMINO-3-ISOPROPYLPYRAZOLO (4,3-D) PYRIMIDINES AS MEDICAMENTS USTAV EXPERIMENTALNI BOTANIKY AV CR V V I (CZ) 2020-04-22 EP disclosed
US-20200087306-A1 2,6-DISUBSTITUTED-9-CYCLOPENTYL-9H-PURINES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2020-03-19 US disclosed
EP-3615535-A1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS Univerzita Palackého v Olomouci (CZ) 2020-03-04 EP disclosed
US-20200054692-A1 ACTIVE SUBSTANCES OF BIFIDOBACTERIUM LACTIS GKK2, COMPOSITION COMPRISING THE SAME AND METHOD OF PROMOTING LONGEVITY USING THE SAME GRAPE KING BIO LTD (TW) 2020-02-20 US disclosed
EP-3601287-A1 2,6-DISUBSTITUTED-9-CYCLOPENTYL-9H-PURINES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS Univerzita Palackého v Olomouci (CZ) 2020-02-05 EP disclosed
WO-2019149295-A1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2019-08-08 WO disclosed
EP-3294741-B1 5-SUBSTITUTED 7-[4-(2-PYRIDYL)PHENYLMETHYLAMINO]-3-ISO PROPYLPYRAZOLO[4,3-D]PYRIMIDINE DERIVATIVES, USE THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS USTAV EXPERIMENTALNI BOTANIKY AV CR V V I (CZ) 2019-05-01 EP disclosed
EP-3233861-B1 6,8-DISUBSTITUTED-9-(HETEROCYCLYL) PURINES, COMPOSITIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN COSMETIC AND MEDICINAL APPLICATIONS USTAV EXPERIMENTALNI BOTANIKY AV CR V V I (CZ) 2019-04-10 EP disclosed
WO-2018196893-A1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2018-11-01 WO disclosed
US-10093675-B2 6,8-disubstituted-9-(heterocyclyl)purines, compositions containing these derivatives and their use in cosmetic and medicinal applications USTAV EXPERIMENTALNI BOTANIKY AV CR, V.V.I. (CZ) 2018-10-09 US disclosed
WO-2018171819-A1 2,6-DISUBSTITUTED-9-CYCLOPENTYL-9H-PURINES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2018-09-27 WO disclosed
WO-2018145886-A1 EDIBLE CONCENTRATE COMPRISING MICROFIBRILLATED CELLULOSE UNILEVER N.V. (NL) 2018-08-16 WO disclosed
EP-3031854-B1 SOFT THERMOPLASTIC RESIN COMPOSITION KANEKA CORP (JP) 2018-06-06 EP disclosed
EP-3325480-A1 5-SUBSTITUTED-7-[4-(SUBSTITUTED)BENZYL]AMINO-3-ISOPROPYLPYRAZOLO(4,3-D)PYRIMIDINES AS MEDICAMENTS Ustav Experimentalni Botaniky Av CR, V.V.I. (CZ) 2018-05-30 EP disclosed
EP-3031855-B1 SOFT THERMOPLASTIC RESIN COMPOSITION KANEKA CORP (JP) 2018-05-23 EP disclosed
US-9957273-B2 5-substituted 7- [4-(2-pyridyl)phenylmethylamino] -3-isopropylpyrazolo4,3-D]pyrimidine derivatives, use thereof as medicaments, and pharmaceutical compositions USTAV EXPERIMENTALNI BOTANIKY AV CR, V.V.I. (CZ) 2018-05-01 US disclosed
EP-3294741-A1 5-SUBSTITUTED 7-[4-(2-PYRIDYL)PHENYLMETHYLAMINO]-3-ISOPROPYLPYRAZOLO4,3-D]PYRIMIDINE DERIVATIVES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS Ustav Experimentalni Botaniky Av CR, V.V.I. (CZ) 2018-03-21 EP disclosed
US-20180072736-A1 5-SUBSTITUTED 7-[4-(2-PYRIDYL)PHENYLMETHYLAMINO]-3-ISOPROPYLPYRAZOLO4,3-D]PYRIMIDINE DERIVATIVES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS USTAV EXPERIMENTALNI BOTANIKY AV CR, V.V.I. (CZ) 2018-03-15 US disclosed
EP-2269663-B1 BONE GRAFT AND BIOCOMPOSITE ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2018-03-07 EP disclosed
US-20170368182-A1 Pharmaceutical Semi-Solid Gels with Entrapped Calcium Phosphate Nanoparticles BELMONT UNIVERSITY 2017-12-28 US disclosed
US-20170362236-A1 6,8-DISUBSTITUTED-9-(HETEROCYCLYL)PURINES, COMPOSITIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN COSMETIC AND MEDICINAL APPLICATIONS USTAV EXPERIMENTALNI BOTANIKY AV CR, V.V.I. (CZ) 2017-12-21 US disclosed
EP-3233861-A1 6,8-DISUBSTITUTED-9-(HETEROCYCLYL)PURINES, COMPOSITIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN COSMETIC AND MEDICINAL APPLICATIONS Ustav Experimentalni Botaniky Av CR, V.V.I. (CZ) 2017-10-25 EP disclosed
EP-1575973-B1 SUBSTITUTION DERIVATIVES OF N SP 6 SP -BENZYLADENOSINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE COMPOUNDS USTAV EXPERIMENTALNI BOTANIKY AV CR V V I (CZ) 2017-08-23 EP disclosed
US-20170175260-A1 CERAMIC/POLYMER COMPOSITE MATERIAL AND METHOD FOR FABRICATING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2017-06-22 US disclosed
EP-2953951-B1 N2-SUBSTITUTED-N6-(6-ARYL-PYRIDINE-3-YLMETHYL)-9-CYCLOPENTYL-9H-PURINE-2,6-DIAMINE DERIVATIVES AS TUMOR SUPPRESSOR P53 ACTIVATORS FOR INHIBITING ANGIOGENESIS AND FOR TREATING CANCER UNIV PALACKEHO (CZ) 2017-05-03 EP disclosed
EP-2438068-B1 SUBSTITUTED 6-(2-HYDROXYBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND COMPOSITIONS CONTAINING THESE DERIVATIVES Univerzita Palackého v Olomouci (CZ) 2017-03-01 EP disclosed
US-9574082-B2 Soft thermoplastic resin composition KANEKA CORPORATION (JP) 2017-02-21 US disclosed
US-9562155-B2 Soft thermoplastic resin composition KANEKA CORPORATION (JP) 2017-02-07 US disclosed
WO-2017012599-A1 5-SUBSTITUTED-7-[4-(SUBSTITUTED)BENZYL]AMINO-3-ISOPROPYLPYRAZOLO(4,3-D)PYRIMIDINES AS MEDICAMENTS USTAV EXPERIMENTALNI BOTANIKY AV CR, V.V.I. (CZ) 2017-01-26 WO disclosed
WO-2016180380-A1 5-SUBSTITUTED 7-[4-(2-PYRIDYL)PHENYLMETHYLAMINO]-3-ISOPROPYLPYRAZOLO4,3-D]PYRIMIDINE DERIVATIVES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS USTAV EXPERIMENTALNI BOTANIKY AV CR, V.V.I. (CZ) 2016-11-17 WO disclosed
EP-2755977-B1 6,8-DISUBSTITUTED PURINE COMPOSITIONS AND THEIR PHARMACEUTICAL AND COSMETIC USE Univerzita Palackého v Olomouci (CZ) 2016-11-02 EP disclosed
US-20160177087-A1 SOFT THERMOPLASTIC RESIN COMPOSITION KANEKA CORPORATION (JP) 2016-06-23 US disclosed
WO-2016095880-A1 6,8-DISUBSTITUTED-9-(HETEROCYCLYL)PURINES, COMPOSITIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN COSMETIC AND MEDICINAL APPLICATIONS USTAV EXPERIMENTALNI BOTANIKY AV CR, V.V.I. (CZ) 2016-06-23 WO disclosed
EP-3031854-A1 SOFT THERMOPLASTIC RESIN COMPOSITION Kaneka Corporation (JP) 2016-06-15 EP disclosed
EP-3031855-A1 SOFT THERMOPLASTIC RESIN COMPOSITION Kaneka Corporation (JP) 2016-06-15 EP disclosed
US-20160160020-A1 SOFT THERMOPLASTIC RESIN COMPOSITION KANEKA CORPORATION (JP) 2016-06-09 US disclosed
US-9334465-B2 Structuring using an external structurant and a cosmotrope THE PROCTER & GAMBLE COMPANY (US) 2016-05-10 US disclosed
US-20150368248-A1 2-SUBSTITUTED-6-BIARYLMETHYLAMINO-9-CYCLOPENTYL-9H-PURINE DERIVATIVES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS BIOPATTERNS S.R.O. (CZ) 2015-12-24 US disclosed
EP-2953951-A2 2-SUBSTITUTED-6-BIARYLMETHYLAMINO-9-CYCLOPENTYL-9H-PURINE DERIVATIVES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS Univerzita palackeho V Olomouci (CZ) 2015-12-16 EP disclosed
US-9174990-B2 2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purines as antiviral agents WAYNE STATE UNIVERSITY (US) 2015-11-03 US disclosed
US-9073961-B2 Substitution derivatives of N6 -benzyladenosine-5′-monophosphate, methods of preparation thereof, use thereof as medicaments, and therapeutic preparations containing these compounds UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2015-07-07 US disclosed
US-9023857-B2 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2015-05-05 US disclosed
EP-2448609-B1 BONE GRAFT AND BIOCOMPOSITE FOR PROSTHETIC DENTISTRY ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2014-10-08 EP disclosed
EP-2391626-B1 SUBSTITUTED 6-(2-AMINOBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND PREPARATIONS CONTAINING THESE COMPOUNDS Univerzita Palackého v Olomouci (CZ) 2014-10-01 EP disclosed
EP-2563801-B1 SUBSTITUTION DERIVATIVES OF N6-BENZYLADENOSINE-5´-MONOPHOSPHATE, METHODS OF PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, AND THERAPEUTIC PREPARATION CONTAINING THESE COMPOUNDS Univerzita Palackého v Olomouci (CZ) 2014-09-24 EP disclosed
US-8834935-B2 Bone graft and biocomposite for prosthetic dentistry ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2014-09-16 US disclosed
EP-2393826-B1 NOVEL SAPONIN COMPOUNDS, METHODS OF PREPARATION THEREOF, USE THEREOF AND PHARMACEUTICAL COMPOSITIONS UNIV W BIALYMSTOKU (PL) 2014-08-27 EP disclosed
WO-2014121764-A2 2-SUBSTITUTED-6-BIARYLMETHYLAMINO-9-CYCLOPENTYL-9H-PURINE DERIVATIVES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2014-08-14 WO disclosed
EP-2430036-B1 SUBSTITUTED 6-(BENZYLAMINO) PURINE RIBOSIDE DERIVATIVES, USE THEREOF AND COMPOSITIONS CONTAINING THESE DERIVATIVES Univerzita Palackého v Olomouci (CZ) 2014-07-30 EP disclosed
EP-2755977-A1 6, 8- DISUBSTITUTED PURINE COMPOSITIONS AND THEIR PHARMACEUTICAL AND COSMETIC USE Univerzita Palackého v Olomouci (CZ) 2014-07-23 EP disclosed
WO-2014099852-A1 IMPROVED STRUCTURING USING AN EXTERNAL STRUCTURANT AND A COSMOTROPE THE PROCTER & GAMBLE COMPANY (US) 2014-06-26 WO disclosed
US-20140179591-A1 STRUCTURING USING AN EXTERNAL STRUCTURANT AND A COSMOTROPE THE PROCTER & GAMBLE COMPANY (US) 2014-06-26 US disclosed
EP-2746377-A1 Improved structuring using an external structurant and a cosmotrope The Procter & Gamble Company (US) 2014-06-25 EP disclosed
US-20140066394-A1 Substituted 6-(Benzylamino) Purine Riboside Derivatives, Use Thereof and Compositions Containing These Derivatives BIOPATTERNS, S.R.O (CZ) 2014-03-06 US disclosed
EP-1419157-B1 6-(4-hydroxybenzylamino)purine and its use in cosmetics USTAV EX BOTAN AKADEMIE VED CESKE REPUBLIKY (CZ) 2013-11-27 EP disclosed
US-8552161-B2 Saponin compounds, methods of preparation thereof, use thereof and pharmaceutical compositions UNIWERSYTET W BIALYMSTOKU (PL) 2013-10-08 US disclosed
US-8552013-B2 Heterocyclic compounds based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds USTAV EXPERIMENTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) 2013-10-08 US disclosed
US-8492391-B2 Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2013-07-23 US disclosed
US-20130072506-A1 6,8-DISUBSTITUTED PURINE COMPOSITIONS ZAHAJSKA LENKA (CZ) 2013-03-21 US disclosed
WO-2013037333-A1 6, 8- DISUBSTITUTED PURINE COMPOSITIONS AND THEIR PHARMACEUTICAL AND COSMETIC USE UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2013-03-21 WO disclosed
EP-2563801-A2 SUBSTITUTION DERIVATIVES OF N6-BENZYLADENOSINE-5´-MONOPHOSPHATE, METHODS OF PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, AND THERAPEUTIC PREPARATION CONTAINING THESE COMPOUNDS Univerzita Palackého v Olomouci (CZ) 2013-03-06 EP disclosed
US-20130040908-A1 SUBSTITUTION DERIVATIVES OF N6-BENZYLADENOSINE-5' -MONOPHOSPHATE, METHODS OF PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, AND THERAPEUTIC PREPARATIONS CONTAINING THESE COMPOUNDS BIOAPEX, S.R.O. (CZ) 2013-02-14 US disclosed
US-8232275-B2 2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and -pyrimidines as antiviral agents WAYNE STATE UNIVERSITY (US) 2012-07-31 US disclosed
EP-2448609-A2 BONE GRAFT AND BIOCOMPOSITE FOR PROSTHETIC DENTISTRY Armbruster Biotechnology GmbH (DE) 2012-05-09 EP disclosed
US-20120107407-A1 BONE GRAFT AND BIOCOMPOSITE FOR PROSTHETIC DENTISTRY ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2012-05-03 US disclosed
EP-2438068-A1 SUBSTITUTED 6-(2-HYDROXYBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND COMPOSITIONS CONTAINING THESE DERIVATIVES Univerzita Palackého v Olomouci (CZ) 2012-04-11 EP disclosed
US-20120071433-A1 Substituted 6-(Benzylamino) Purine Riboside Derivatives, Use Thereof and Compositions Containing These Derivatives UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2012-03-22 US disclosed
US-20120070512-A1 Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives BIOPATTERNS, S.R.O (CZ) 2012-03-22 US disclosed
EP-2430036-A1 SUBSTITUTED 6-(BENZYLAMINO) PURINE RIBOSIDE DERIVATIVES, USE THEREOF AND COMPOSITIONS CONTAINING THESE DERIVATIVES Univerzita Palackého v Olomouci (CZ) 2012-03-21 EP disclosed
US-8119614-B2 Substitution derivatives of N6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds USTAV EXPERIMENTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) 2012-02-21 US disclosed
WO-2011134444-A9 SUBSTITUTION DERIVATIVES OF N6-BENZYLADENOSINE-5´-MONOPHOSPHATE, METHODS OF PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, AND THERAPEUTIC PREPARATION CONTAINING THESE COMPOUNDS UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2012-02-16 WO disclosed
US-20110311652-A1 Novel Saponin Compounds, Methods of Preparation Thereof, Use Thereof and Pharmaceutical Compositions UNIWERSYTET W BIALYMSTOKU (PL) 2011-12-22 US disclosed
EP-2393826-A2 NOVEL SAPONIN COMPOUNDS, METHODS OF PREPARATION THEREOF, USE THEREOF AND PHARMACEUTICAL COMPOSITIONS Uniwersytet w Bialymstoku (PL) 2011-12-14 EP disclosed
EP-2391626-A2 SUBSTITUTED 6-(2-AMINOBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND PREPARATIONS CONTAINING THESE COMPOUNDS Univerzita Palackého v Olomouci (CZ) 2011-12-07 EP disclosed
US-20110287111-A1 SUBSTITUTED 6-(2-AMINOBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND PREPARATIONS CONTAINING THESE COMPOUNDS UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2011-11-24 US disclosed
US-20110275652-A1 2,2-BIS-(HYDROXYMETHYL)CYCLOPROPYLIDENEMETHYL-PURINES AND -PYRIMIDINES AS ANTIVIRAL AGENTS WAYNE STATE UNIVERSITY 2011-11-10 US disclosed
WO-2011134444-A2 SUBSTITUTION DERIVATIVES OF N6-BENZYLADENOSINE-5´-MONOPHOSPHATE, METHODS OF PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, AND THERAPEUTIC PREPARATION CONTAINING THESE COMPOUNDS UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2011-11-03 WO disclosed
EP-1490368-B1 2,2-BIS(HYDROXYMETHYL)CYCLOPROPYLIDENEMETHYL - PURINES AND -PYRIMIDINES AS ANTIVIRAL AGENTS UNIV WAYNE STATE (US) 2011-08-03 EP disclosed
WO-2011000970-A2 BONE GRAFT AND BIOCOMPOSITE FOR PROSTHETIC DENTISTRY ARMBRUSTER BIOTECHNOLOGY GMBH (DE) 2011-01-06 WO disclosed
EP-2269663-A2 Bone graft and biocomposite for prosthetic dentistry Armbruster Biotechnology GmbH (DE) 2011-01-05 EP disclosed
WO-2010139288-A1 5,7-DISUBSTITUTED 3-ISOPROPYLPYRAZOLO[4,3-D]PYRIMIDINES FOR USE AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS C3 BIO GMBH (DE) 2010-12-09 WO disclosed
WO-2010139289-A1 SUBSTITUTED 6-(2-HYDROXYBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND COMPOSITIONS CONTAINING THESE DERIVATIVES UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2010-12-09 WO disclosed
WO-2010130233-A1 SUBSTITUTED 6-(BENZYLAMINO) PURINE RIBOSIDE DERIVATIVES, USE THEREOF AND COMPOSITIONS CONTAINING THESE DERIVATIVES UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2010-11-18 WO disclosed
US-7816350-B2 Substituted [1,2,3] triazolo[4,5-D]pyrimidines as cdk inhibitors INSTITUTE OF EXPERIMENTAL BOTANY ASCR (CZ) 2010-10-19 US disclosed
EP-2235036-A1 SACCHARIDE LUPANE DERIVATIVES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES Universita Palackeho v Olomouci (CZ) 2010-10-06 EP disclosed
US-20100249259-A1 HARD FOAM JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) 2010-09-30 US disclosed
EP-2222690-A2 NATURAL BRASSINOSTEROIDS FOR USE FOR TREATING HYPERPROLIFERATION, TREATING PROLIFERATIVE DISEASES AND REDUCING ADVERSE EFFECTS OF STEROID DYSFUNCTION IN MAMMALS, PHARMACEUTICAL COMPOSITION AND ITS USE Ustav Organicke Chemie A Biochemie Akademie Ved Ceske Republiky (CZ) 2010-09-01 EP disclosed
EP-1348707-B1 Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy USTAV EX BOTAN AV CR V V I I O (CZ) 2010-08-25 EP disclosed
US-20100204460-A1 NATURAL BRASSINOSTEROIDS FOR USE FOR TREATING HYPERPROLIFERATION, TREATING PROLIFERATIVE DISEASES AND REDUCING ADVERSE EFFECTS OF STEROID DYSFUNCTION IN MAMMALS, PHARMACEUTICAL COMPOSITION AND ITS USE USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED EESKE REPUBLIKY, V.V.I. (CZ) 2010-08-12 US disclosed
WO-2010088866-A2 NOVEL SAPONIN COMPOUNDS, METHODS OF PREPARATION THEREOF, USE THEREOF AND PHARMACEUTICAL COMPOSITIONS UNIWERSYTET W BIALYMSTOKU (PL) 2010-08-12 WO disclosed
WO-2010085924-A2 SUBSTITUTED 6-(2-AMINOBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND PREPARATIONS CONTAINING THESE COMPOUNDS UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2010-08-05 WO disclosed
US-7745450-B2 Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy INSTITUTE OF EXPERIMENTAL BOTANY (CZ) 2010-06-29 US disclosed
US-20090312392-A1 Amino ceramide-like compounds and therapeutic methods of use NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2009-12-17 US disclosed
EP-1358172-B1 AMINO CERAMIDE-LIKE COMPOUNDS AND THERAPEUTIC METHODS OF USE UNIV MICHIGAN (US) 2009-11-18 EP disclosed
EP-1490015-B1 NOVEL 2-AMINO-9-((2-HYDROXYMETHYL) CYCLOPROPYLIDENEMETHYL) PURINES AS ANTIVIRAL AGENTS UNIV WAYNE STATE (US) 2009-09-23 EP disclosed
WO-2009094958-A1 SACCHARIDE LUPANE DERIVATIVES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2009-08-06 WO disclosed
US-20090118308-A1 2,2-Bis-(hydroxymethyl)cyclopropylidenemethyl-Purines and -Pyrimidines As Antiviral Agents WAYNE STATE UNIVERSITY (US) 2009-05-07 US disclosed
WO-2009024103-A2 NATURAL BRASSINOSTEROIDS FOR USE FOR TREATING HYPERPROLIFERATION, TREATING PROLIFERATIVE DISEASES AND REDUCING ADVERSE EFFECTS OF STEROID DYSFUNCTION IN MAMMALS, PHARMACEUTICAL COMPOSITION AND ITS USE USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CESKE REPUBLIKY, V.V.I. (CZ) 2009-02-26 WO disclosed
US-7393855-B2 2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and pyrimidines as antiviral agents THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-07-01 US disclosed
US-20080146533-A1 Amino ceramide-like compounds and therapeutic methods of use NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2008-06-19 US disclosed
US-7335681-B2 Amino ceramide-like compounds and therapeutic methods of use THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-02-26 US disclosed
US-20080014227-A1 HETEROCYCLIC COMPOUNDS BASED ON N6-SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE COMPOUNDS USTAV EXPERIMENTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) 2008-01-17 US disclosed
US-7279482-B2 Heterocyclic compound based on N6-substituted adenine, methods, of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds Ústav experimentálni botaniky Akademie ved Ceské republiky (CZ) 2007-10-09 US disclosed
US-20070225302-A1 2-Amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purines as antiviral agents NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-09-27 US disclosed
WO-2007095666-A1 AN IMPROVED GOLF TEE AND METHOD OF MANUFACTURE SAFE-TEES DOWN UNDER PTY LTD (AU) 2007-08-30 WO disclosed
US-7253185-B2 Amino ceramide-like compounds and therapeutic methods of use THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2007-08-07 US disclosed
US-20070072916-A1 Amino ceramide-like compounds and therapeutic methods of use THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2007-03-29 US disclosed
US-7183268-B2 2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents WAYNE STATE UNIVERSITY (US) 2007-02-27 US disclosed
US-7148251-B2 Amino ceramide-like compounds and therapeutic methods of use THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2006-12-12 US disclosed
US-20060217560-A1 Amino ceramide-like compounds and therapeutic methods of use NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2006-09-28 US disclosed
US-20060166925-A1 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds USTAV EXPERIMENTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) 2006-07-27 US disclosed
EP-1490368-A4 2,2-BIS(HYDROXYMETHYL)CYCLOPROPYLIDENEMETHYL - PURINES AND -PYRIMIDINES AS ANTIVIRAL AGENTS UNIV WAYNE STATE (US) 2006-07-19 EP disclosed
US-20060122203-A1 2-Hydroxymethylcyclopropylidenemethylpurines and - pyrimidines as antiviral agents NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2006-06-08 US disclosed
EP-1244668-B1 PURINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USE THEREOF UNIVERSITAIRE INSTELLING ANTWE (BE) 2006-04-05 EP disclosed
US-20060035909-A1 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2006-02-16 US disclosed
EP-1490015-A4 NOVEL 2-AMINO-9-((2-HYDROXYMETHYL) CYCLOPROPYLIDENEMETHYL) PURINES AS ANTIVIRAL AGENTS UNIV WAYNE STATE (US) 2005-12-28 EP disclosed
US-20050267094-A1 Amino ceramide-like compounds and therapeutic methods of use THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2005-12-01 US disclosed
US-20050239862-A1 Amino ceramide-like compounds and therapeutic methods of use THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2005-10-27 US disclosed
US-6958345-B2 2-hydroxymethylcyclopropylidene methylpurines and -pyrimidines as antiviral agents THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2005-10-25 US disclosed
EP-1575973-A2 SUBSTITUTION DERIVATIVES OF N SP 6 SP -BENZYLADENOSINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE COMPOUNDS Ustav Experimentalni Botaniky Akademie ved Ceské Republiky (CZ) 2005-09-21 EP disclosed
US-6916802-B2 Amino ceramide-like compounds and therapeutic methods of use GENZYME CORPORATION (US) 2005-07-12 US disclosed
EP-1539760-A2 AZAPURINE DERIVATIVES INSTITUTE OF EXPERIMENTAL BOTANY ASCR (CZ) 2005-06-15 EP disclosed
US-20050124582-A1 2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-06-09 US disclosed
US-20050113393-A1 2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and pyrmindines as antiviral agents WAYNE STATE UNIVERSITY (US) 2005-05-26 US disclosed
US-6890949-B1 Amino ceramide-like compounds and therapeutic methods of use THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2005-05-10 US disclosed
US-20050080097-A1 Pyrazolo[4,3-D]pyrimidines, processes for their preparation and methods for therapy USTAV EXPERIMENTALNI BOTANIKY AV CR (INSTITUTE OF EXPERIMENTAL BOTANY ACADEMY OF 2005-04-14 US disclosed
US-20050049235-A1 Amino ceramide-like compounds and therapeutic methods of use THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2005-03-03 US disclosed
US-20050043328-A1 Heterocyclic compound based on n6-substituted adenine, methods, of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds USTAV EPERIMENTALNI BOTANIKY AKADEMI VED CESKE REPUBILIKY (CZ) 2005-02-24 US disclosed
US-20050009842-A1 2-hydroxymethylcyclopropylidene methylpurines and -pyrimidines as antiviral agents NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2005-01-13 US disclosed
EP-1490368-A2 2,2-BIS(HYDROXYMETHYL)CYCLOPROPYLIDENEMETHYL - PURINES AND -PYRIMIDINES AS ANTIVIRAL AGENTS Wayne State University (US) 2004-12-29 EP disclosed
EP-1490015-A2 NOVEL 2-AMINO-9-((2-HYDROXYMETHYL) CYCLOPROPYLIDENEMETHYL) PURINES AS ANTIVIRAL AGENTS Wayne State University (US) 2004-12-29 EP disclosed
US-20040260099-A1 Amino ceramide-like compounds and therapeutic methods of use THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2004-12-23 US disclosed
EP-1165560-B1 2-HYDROXY METHYLCYCLOPRO PYLIDENEMETHYL PURINES AS ANTIVIRAL AGENTS UNIV MICHIGAN (US) 2004-11-17 EP disclosed
US-6790841-B2 FOR THERAPY OF MAMMAL INFECTED WITH VIRUS WAYNE STATE UNIVERSITY 2004-09-14 US disclosed
WO-2004058791-A2 SUBSTITUTION DERIVATIVES OF N6-BENZYLADENOSINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE COMPOUNDS USTAV EXPERIMENTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) 2004-07-15 WO disclosed
EP-1419157-A2 HETEROCYCLIC COMPOUND BASED ON N sp 6 /sp −SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE Ustav Experimentalni Botaniky Akademie ved Ceské Republiky (CZ) 2004-05-19 EP disclosed
WO-2004018473-A2 AZAPURINE DERIVATIVES INSTITUTE OF EXPERIMENTAL BOTANY ASCR (CZ) 2004-03-04 WO disclosed
EP-1384719-A1 Inhibitors of the glucosyl ceramide synthase enzyme useful for the treatment of cancers, sphingolipidosis and microbial infections The Regents of The University of Michigan (US) 2004-01-28 EP disclosed
WO-2004006867-A2 2-AMINO-9-[(2-HYDROXYMETHYL) CYCLOPROPYLIDENEMETHYL] PURINE ANTIVIRAL AGENTS WAYNE STATE UNIVERSITY (US) 2004-01-22 WO disclosed
WO-2003104440-A2 2,2-BIS(HYDROXYMETHYL)CYCLOPROPYLIDENEMETHYL - PURINES AND -PYRIMIDINES AS ANTIVIRAL AGENTS WAYNE STATE UNIVERSITY (US) 2003-12-18 WO disclosed
EP-1358172-A2 AMINO CERAMIDE-LIKE COMPOUNDS AND THERAPEUTIC METHODS OF USE The Regents of The University of Michigan (US) 2003-11-05 EP disclosed
WO-2003082872-A1 NOVEL PYRAZOLO[4,3-D]PYRIMIDINES, PROCESSES FOR THEIR PREPARATION AND METHODS FOR THERAPY USTAV EXPERIMENTALNI BOTANIKY AV CR (INSTITUTE OF EXPERIMENTAL BOTANY ACADEMY OF SCIENCES OF THE CZECH REPUBLIC) (CZ) 2003-10-09 WO disclosed
US-20030187261-A1 Purine derivatives, process for their preparation and use thereof USTAV EXPERIMANTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) 2003-10-02 US disclosed
EP-1348707-A1 Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy Ustav Experimentalni Botaniky AV CR (Institute of Experimental Botany Academy of Sciences of the Czech Republic) (CZ) 2003-10-01 EP disclosed
US-6569889-B2 Anticarcinogenic agents THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2003-05-27 US disclosed
WO-2003040144-A2 HETEROCYCLIC COMPOUND BASED ON N6-SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE COMPOUNDS USTAV EXPERIMENTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) 2003-05-15 WO disclosed
US-20030073680-A1 Amino ceramide-like compounds and therapeutic methods of use THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2003-04-17 US disclosed
WO-2002062777-A9 AMINO CERAMIDE-LIKE COMPOUNDS AND THERAPEUTIC METHODS OF USE UNIV MICHIGAN (US) 2003-01-09 WO disclosed
US-20020198240-A1 Amino ceramide - like compounds and therapeutic methods of use REGENTS OF THE UNIVERSITY OF MICHIGAN, THE 2002-12-26 US disclosed
US-20020193353-A1 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents WAYNE STATE UNIVERSITY 2002-12-19 US disclosed
US-20020156107-A1 Amino ceramide - like compounds and therapeutic methods of use NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-10-24 US disclosed
EP-1244668-A1 PURINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USE THEREOF UNIVERSITAIRE INSTELLING ANTWERPEN (BE) 2002-10-02 EP disclosed
WO-2002062777-A2 AMINO CERAMIDE-LIKE COMPOUNDS AND THERAPEUTIC METHODS OF USE THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2002-08-15 WO disclosed
WO-2000053603-A9 2-HYDROXY METHYLCYCLOPRO PYLIDENEMETHYL PURINES AND -PYRIMIDINES AS ANTIVIRAL AGENTS UNIV MICHIGAN (US) 2002-05-10 WO disclosed
EP-1165560-A4 2-HYDROXY METHYLCYCLOPRO PYLIDENEMETHYL PURINES AND -PYRIMIDINES AS ANTIVIRAL AGENTS UNIV MICHIGAN (US) 2002-04-17 EP disclosed
EP-1196406-A1 AMINO CERAMIDE-LIKE COMPOUNDS AND THERAPEUTIC METHODS OF USE The Regents of the University of Michigan (US) 2002-04-17 EP disclosed
US-6352991-B1 VIRICIDES FOR TREATMENT OF AIDS WAYNE STATE UNIVERSITY 2002-03-05 US disclosed
EP-1165560-A1 2-HYDROXY METHYLCYCLOPRO PYLIDENEMETHYL PURINES AND -PYRIMIDINES AS ANTIVIRAL AGENTS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2002-01-02 EP disclosed
US-20010041735-A1 Amino ceramide - like compounds and therapeutic methods of use NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2001-11-15 US disclosed
WO-2001049688-A1 PURINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USE THEREOF UNIVERSITAIRE INSTELLING ANTWERPEN (BE) 2001-07-12 WO disclosed
US-6255336-B1 REDUCING CONCENTRATION OF GLYCOSPHINGOLIPIDS; SYNTHASE INHIBITORS THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2001-07-03 US disclosed
JP-2001072502-A SLIMICIDE NIPPON SODA CO LTD 2001-03-21 JP disclosed
WO-2001004108-A1 AMINO CERAMIDE-LIKE COMPOUNDS AND THERAPEUTIC METHODS OF USE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2001-01-18 WO disclosed
US-6127439-A MONOMERS ARE PARTIALLY POLYMERIZED AND THEN SUSPENDED IN WATER SO THAT THE RESULTING BEADS CONTAIN FROM 3 TO 40 WEIGHT % WATER WHICH ACTS AS SOLE OR A PREDOMINANT BLOWING AGENT NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2000-10-03 US disclosed
EP-0912630-B1 PROCESS FOR THE PREPARATION OF POLYMER PARTICLES SHELL INT RESEARCH (NL) 2000-09-20 EP disclosed
WO-2000053603-A1 2-HYDROXY METHYLCYCLOPRO PYLIDENEMETHYL PURINES AND -PYRIMIDINES AS ANTIVIRAL AGENTS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2000-09-14 WO disclosed
EP-0912630-A1 PROCESS FOR THE PREPARATION OF POLYMER PARTICLES SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1999-05-06 EP disclosed
US-5783635-A ARTIFICIAL MARBLE, PARTICLES OF CROSSLINKED DIVINYLBENZENE-STYRENE RESIN, GLASS OR ALUMINUM HYDROXIDE POWDER FILLER, BATHROOM AND KITCHEN FIXTURES AND COUNTERS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-07-21 US disclosed
WO-1998030563-A1 2-HYDROXYMETHYLCYCLOPROPYLI- DENEMETHYLPURINES AND -PYRIMIDINES AS ANTIVIRAL AGENTS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 1998-07-16 WO disclosed
WO-1998001501-A1 PROCESS FOR THE PREPARATION OF POLYMER PARTICLES SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 1998-01-15 WO disclosed
EP-0806454-A2 An unsaturated polyester resin composition Takeda Chemical Industries, Ltd. (JP) 1997-11-12 EP disclosed
US-5429762-A Cooling agent JAPAN PIONICS CO., LTD. (JP) 1995-07-04 US disclosed
EP-0608789-A1 Cooling agent JAPAN PIONICS CO., LTD. (JP) 1994-08-03 EP disclosed
EP-0474639-A1 GENERAL PURPOSE FERTILISER McKenzie, David Lawrence (GB) 1992-03-18 EP disclosed
WO-1990011265-A2 GENERAL PURPOSE FERTILISER MCKENZIE DAVID LAWRENCE (GB) 1990-10-04 WO disclosed
JP-H01101976-A BONE CEMENT COMPONENT SUMITOMO CEMENT CO LTD 1989-04-19 JP disclosed
JP-H01101977-A MANUFACTURE OF APATITE COVER SUMITOMO CEMENT CO LTD 1989-04-19 JP disclosed
JP-S63238022-A ISOLATION OF HBE ANTIGEN KURARAY CO LTD 1988-10-04 JP disclosed
EP-0169926-B1 POLYESTER COMPOSITION TEIJIN LIMITED (JP) 1988-05-18 EP disclosed
JP-S61247610-A PREPARATION OF TRICALCIUM DIPHOSPHATE KANTO KAGAKU KK 1986-11-04 JP disclosed
EP-0169926-A1 Polyester composition TEIJIN LIMITED (JP) 1986-02-05 EP disclosed
US-4563207-A MANURE, POTASSIUM COMPOUND, PHOSPHATE AND CALCIUM CARBONATE MCKENZIE DAVID L 1986-01-07 US disclosed
US-4513114-A CONTAINING DISPERSOID PARTICLES OR AGGLOMERATES TEIJIN LIMITED (JP) 1985-04-23 US disclosed
US-4513114-A CONTAINING DISPERSOID PARTICLES OR AGGLOMERATES TEIJIN LIMITED (JP) 1985-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (49 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110287111-A1 SUBSTITUTED 6-(2-AMINOBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND PREPARATIONS CONTAINING THESE COMPOUNDS CDK6, CCNI, CDK2 FDPS 866/4885BLM 1536/4885TDP1 273/4885
US-20140066394-A1 Substituted 6-(Benzylamino) Purine Riboside Derivatives, Use Thereof and Compositions Containing These Derivatives PNP, NUDT1, TYMP FDPS 1369/4885BLM 561/4885TDP1 329/4885
US-20180072736-A1 5-SUBSTITUTED 7-[4-(2-PYRIDYL)PHENYLMETHYLAMINO]-3-ISOPROPYLPYRAZOLO4,3-D]PYRIMIDINE DERIVATIVES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS CDK5, CDK2, CDK4 FDPS 2091/4885BLM 3742/4885TDP1 1976/4885
US-20040260099-A1 Amino ceramide-like compounds and therapeutic methods of use UGCG, CERS2, CERT1 FDPS 357/4885BLM 4857/4885TDP1 2029/4885
US-20110275652-A1 2,2-BIS-(HYDROXYMETHYL)CYCLOPROPYLIDENEMETHYL-PURINES AND -PYRIMIDINES AS ANTIVIRAL AGENTS TPMT, HPRT1, MTAP FDPS 585/4885BLM 1871/4885TDP1 286/4885
US-20080014227-A1 HETEROCYCLIC COMPOUNDS BASED ON N6-SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE COMPOUNDS TYMP, CCNB1, CCNA2 FDPS 346/4885BLM 1594/4885TDP1 967/4885
US-12636299-B2 Terpenoid derivatives, pharmaceutical preparations containing these derivatives and their use in neuroprotection GALC, HK1, SNCA FDPS 3194/4885BLM 4827/4885TDP1 1367/4885
US-20100204460-A1 NATURAL BRASSINOSTEROIDS FOR USE FOR TREATING HYPERPROLIFERATION, TREATING PROLIFERATIVE DISEASES AND REDUCING ADVERSE EFFECTS OF STEROID DYSFUNCTION IN MAMMALS, PHARMACEUTICAL COMPOSITION AND ITS USE BRDT, NR5A1, BRSK2 FDPS 1796/4885BLM 3752/4885TDP1 3392/4885
US-20060166925-A1 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds ADAR, ADORA2A, AMPD2 FDPS 1069/4885BLM 1256/4885TDP1 1147/4885
US-20050080097-A1 Pyrazolo[4,3-D]pyrimidines, processes for their preparation and methods for therapy CBR3, DHFR, AKR1C3 FDPS 812/4885BLM 400/4885TDP1 2367/4885
US-20090312392-A1 Amino ceramide-like compounds and therapeutic methods of use UGCG, CERS2, SGMS1 FDPS 523/4885BLM 4798/4885TDP1 2433/4885
US-20020198240-A1 Amino ceramide - like compounds and therapeutic methods of use UGCG, CERS2, CERT1 FDPS 357/4885BLM 4857/4885TDP1 2029/4885
US-20050239862-A1 Amino ceramide-like compounds and therapeutic methods of use UGCG, CERS2, CERT1 FDPS 438/4885BLM 4856/4885TDP1 2567/4885
US-20060122203-A1 2-Hydroxymethylcyclopropylidenemethylpurines and - pyrimidines as antiviral agents HPRT1, TPMT, NUDT1 FDPS 1644/4885BLM 1690/4885TDP1 377/4885
US-20050043328-A1 Heterocyclic compound based on n6-substituted adenine, methods, of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds ATIC, UMPS, CCNB1 FDPS 304/4885BLM 1551/4885TDP1 1656/4885
US-20050009842-A1 2-hydroxymethylcyclopropylidene methylpurines and -pyrimidines as antiviral agents TPMT, HPRT1, MTAP FDPS 1541/4885BLM 1693/4885TDP1 366/4885
US-20200087306-A1 2,6-DISUBSTITUTED-9-CYCLOPENTYL-9H-PURINES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS FLT3, CDK9, CDK6 FDPS 826/4885BLM 1656/4885TDP1 802/4885
US-20120071433-A1 Substituted 6-(Benzylamino) Purine Riboside Derivatives, Use Thereof and Compositions Containing These Derivatives CD38, NUDT1, PNP FDPS 1123/4885BLM 861/4885TDP1 367/4885
US-20220127269-A1 HETEROCYCLIC NITROGEN-CONTAINING PURINE DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN NEUROPROTECTION NME4, NLN, PNP FDPS 1168/4885BLM 1942/4885TDP1 63/4885
US-20010041735-A1 Amino ceramide - like compounds and therapeutic methods of use UGCG, CERS2, CERT1 FDPS 458/4885BLM 4837/4885TDP1 2739/4885
US-20150368248-A1 2-SUBSTITUTED-6-BIARYLMETHYLAMINO-9-CYCLOPENTYL-9H-PURINE DERIVATIVES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS ENTPD5, PNP, HCCS FDPS 421/4885BLM 920/4885TDP1 2150/4885
US-20170362236-A1 6,8-DISUBSTITUTED-9-(HETEROCYCLYL)PURINES, COMPOSITIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN COSMETIC AND MEDICINAL APPLICATIONS PNP, UNG, NUDT1 FDPS 514/4885BLM 680/4885TDP1 47/4885
US-20200361943-A1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA TK1, DCK, CCNK FDPS 2001/4885BLM 2796/4885TDP1 324/4885
US-20200157105-A1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS ADORA2A, UNG, P2RY6 FDPS 1612/4885BLM 1739/4885TDP1 31/4885
US-20120070512-A1 Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives CDK6, CCNI, CDK2 FDPS 1027/4885BLM 1075/4885TDP1 484/4885
US-20130040908-A1 SUBSTITUTION DERIVATIVES OF N6-BENZYLADENOSINE-5' -MONOPHOSPHATE, METHODS OF PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, AND THERAPEUTIC PREPARATIONS CONTAINING THESE COMPOUNDS MTAP, RNMT, NUDT1 FDPS 723/4885BLM 311/4885TDP1 767/4885
US-10093675-B2 6,8-disubstituted-9-(heterocyclyl)purines, compositions containing these derivatives and their use in cosmetic and medicinal applications PNP, UNG, NUDT1 FDPS 514/4885BLM 680/4885TDP1 47/4885
US-20050267094-A1 Amino ceramide-like compounds and therapeutic methods of use UGCG, CERS2, SGMS1 FDPS 523/4885BLM 4798/4885TDP1 2433/4885
US-20050113393-A1 2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and pyrmindines as antiviral agents TPMT, HPRT1, MTAP FDPS 793/4885BLM 1759/4885TDP1 280/4885
US-20080146533-A1 Amino ceramide-like compounds and therapeutic methods of use UGCG, CERS2, SGMS1 FDPS 523/4885BLM 4798/4885TDP1 2433/4885
US-20230414645-A1 TERPENOID DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THEIR USE IN NEUROPROTECTION HTT, SNCA, BDNF FDPS 562/4885BLM 4405/4885TDP1 458/4885
US-11643413-B2 9-(2-oxacycloalkyl)-9H-purine-2,6-diamine derivatives and their use for the treatment of skin disorders ADORA2A, UNG, P2RY6 FDPS 1612/4885BLM 1739/4885TDP1 31/4885
US-20230365616-A1 CHOLESTANE DERIVATIVES, PREPARATIONS CONTAINING THESE DERIVATIVES AND USE THEREOF BAD, CYP27A1, NPC1L1 FDPS 1098/4885BLM 2220/4885TDP1 1031/4885
US-20030187261-A1 Purine derivatives, process for their preparation and use thereof DCK, DTYMK, CCNK FDPS 499/4885BLM 2208/4885TDP1 1089/4885
US-20070225302-A1 2-Amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purines as antiviral agents HAVCR2, ORC3, HPRT1 FDPS 2146/4885BLM 2783/4885TDP1 1514/4885
US-20110311652-A1 Novel Saponin Compounds, Methods of Preparation Thereof, Use Thereof and Pharmaceutical Compositions CYP4A11, CYP11B1, CYP11B2 FDPS 402/4885BLM 2281/4885TDP1 4478/4885
US-20030073680-A1 Amino ceramide-like compounds and therapeutic methods of use UGCG, CERS2, SGMS1 FDPS 523/4885BLM 4798/4885TDP1 2433/4885
US-11028087-B2 2,6-disubstituted-9-cyclopentyl-9H-purines, use thereof as medicaments, and pharmaceutical compositions FLT3, CDK9, CDK6 FDPS 826/4885BLM 1656/4885TDP1 802/4885
US-20090118308-A1 2,2-Bis-(hydroxymethyl)cyclopropylidenemethyl-Purines and -Pyrimidines As Antiviral Agents TPMT, HPRT1, MTAP FDPS 585/4885BLM 1871/4885TDP1 286/4885
US-20070072916-A1 Amino ceramide-like compounds and therapeutic methods of use UGCG, CERS2, CERT1 FDPS 357/4885BLM 4857/4885TDP1 2029/4885
US-20050049235-A1 Amino ceramide-like compounds and therapeutic methods of use UGCG, CERS2, SGMS1 FDPS 523/4885BLM 4798/4885TDP1 2433/4885
US-20020193353-A1 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents TPMT, HPRT1, MTAP FDPS 1922/4885BLM 1729/4885TDP1 266/4885
US-11186583-B2 5-alkylthio-7-[(4-arylbenzyl)amino]-1(2)H-pyrazolo[4,3-d]pyrimidines for treatment of lymphoma TK1, DCK, CCNK FDPS 2001/4885BLM 2796/4885TDP1 324/4885
US-20130072506-A1 6,8-DISUBSTITUTED PURINE COMPOSITIONS UNG, PNP, UMPS FDPS 613/4885BLM 532/4885TDP1 45/4885
US-20060035909-A1 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout CDK8, CDK6, CDK1 FDPS 2309/4885BLM 4722/4885TDP1 1166/4885
US-20050124582-A1 2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents HAVCR2, ORC3, NSUN2 FDPS 2365/4885BLM 2818/4885TDP1 1454/4885
US-12319694-B2 Heterocyclic nitrogen-containing purine derivatives, pharmaceutical preparations containing these derivatives and their use in neuroprotection NME4, NLN, PNP FDPS 1168/4885BLM 1942/4885TDP1 63/4885
US-20060217560-A1 Amino ceramide-like compounds and therapeutic methods of use UGCG, CERS2, CERT1 FDPS 357/4885BLM 4857/4885TDP1 2029/4885
US-20020156107-A1 Amino ceramide - like compounds and therapeutic methods of use UGCG, CERS2, CERT1 FDPS 357/4885BLM 4857/4885TDP1 2029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.